Comparison Chart Myriad Genetics, Inc.
Stocks
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
21:00:00 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.890 USD | -6.04% |
|
+13.74% | -36.75% |
| 09-16 | Myriad Genetics, Inc. Announces Management Changes | CI |
| 09-09 | UBS Adjusts Price Target on Myriad Genetics to $3.60 From $6, Keeps Neutral Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MYRIAD GENETICS, INC. | Diagnostic & Testing Substances | -6.04% | +13.74% | -36.75% | -49.35% | -88.46% | 372M |  |  | |
- Stock Market
- Stocks
- MYGN Stock
- Charts Myriad Genetics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
